Georgeen Gaza‐Bulseco
Georgeen Gaza‐Bulseco publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Spectroscopy, on topics such as Protein purification and stability, Monoclonal and Polyclonal Antibodies Research and Glycosylation and Glycoproteins Research.
- World rank
- #894,505 of 7,710,434 ranked researchers
- Rank in United States
- #295,216 of 1,627,098
- Works
- 26
- Citations
- 2k
- Citations per work
- 78.6
What does Georgeen Gaza‐Bulseco research?
Georgeen Gaza‐Bulseco's work is mostly in Biochemistry, Genetics and Molecular Biology (49%), Medicine (21%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1455.3%
- Health Sciences521.1%
- Medicine521.1%
- Everything else313.1%
- Physical Sciences310.5%
- Chemistry26.6%
- Materials Science13.9%
- 1Molecular Biology46% of their works
- 2Radiology, Nuclear Medicine and Imaging21% of their works
- 3Spectroscopy7% of their works
- 4Immunology7% of their works
- 5Materials Chemistry4% of their works
- 6Cell Biology3% of their works
Research topics
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- Glycosylation and Glycoproteins Research
- Viral Infectious Diseases and Gene Expression in Insects
- Biosimilars and Bioanalytical Methods
- Mass Spectrometry Techniques and Applications
- Enzyme Structure and Function
- Reproductive System and Pregnancy
Which keywords describe Georgeen Gaza‐Bulseco's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Biopharmaceuticals, Immunogenicity, Protein Aggregation, Recombinant Proteins and Antibody Engineering.
- Decidual NK Cells
- Mass Spectrometry
- Ionization
- Bioanalytical Methods
- Mammalian Cells
- Cancer
- Antibody Engineering
- Protein Aggregation
- Biopharmaceuticals
- Therapeutic Antibodies
- Monoclonal Antibodies
- Glycosylation
- Immunogenicity
- Recombinant Proteins
- Fc Receptors
- Glycans
- Recombinant Protein
- Biosimilars
- Macromolecular Crystallography
- Structure Solution
- Regulatory T Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Monoclonal Antibodies393 topics
- Therapeutic Antibodies362 topics
- Glycosylation283 topics
- Biopharmaceuticals232 topics
- Immunogenicity232 topics
- Protein Aggregation201 topic
- Recombinant Proteins201 topic
- Antibody Engineering161 topic
- Fc Receptors161 topic
- Cancer61 topic
- Glycans61 topic
- Mammalian Cells61 topic
- Recombinant Protein61 topic
- Bioanalytical Methods31 topic
- Biosimilars31 topic
- Ionization31 topic
- Macromolecular Crystallography31 topic
- Mass Spectrometry31 topic
- Structure Solution31 topic
- Decidual NK Cells21 topic
- Regulatory T Cells21 topic
Where does Georgeen Gaza‐Bulseco work?
Georgeen Gaza‐Bulseco's main affiliation in the publication record is Abbott (United States), United States.
How many publications and citations does Georgeen Gaza‐Bulseco have?
OpenAlex counts 26 works and 2,044 citations for Georgeen Gaza‐Bulseco, an h-index of 20, ranking #894,505 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Georgeen Gaza‐Bulseco. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.